AKT1 and leukemia: Wiench et al. reported that integration of bioinformatics and three “-omics” assays demonstrated that SHK affected the PI3K/AKT pathways in leukemia cells, and a decrease in phosphorylated AKT was observed after SHK treatment (Wiench et al., 2013).